Part V. Laboratory diagnosis of Chagas disease;Parte V. Diagnóstico de laboratorio

Revista Chilena de Infectologia

Volumn 25, Issue 5, 2008, Pages 380-383

  Apt B , Werner ^a   Heitmann G , Ingrid ^a   Jercic L , M Isabel ^a   Jofré M , Leonor ^a   Muñoz C Del V , Patricia ^a   Noemí H , Isabel ^a   San Martín V , Ana M ^a   Sapunar P , Jorge ^a   Torres H , Marisa ^a   Zulantay A , Inés ^a  

^a Ministerio de Salud de Chile   (Chile)

Author keywords

American trypanosomiasis; Chagas disease; Diagnosis; Laboratory techniques

Indexed keywords

PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ALGORITHM; ANIMAL; BLOOD; CHAGAS DISEASE; CHILE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOLOGY; PARASITOLOGY; PRACTICE GUIDELINE; REVIEW; TRYPANOSOMA CRUZI;

ALGORITHMS; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CHILE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; TRYPANOSOMA CRUZI;

EID: 53849111978     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Apt W, Aguilera X, Arribada A, Pérez C, Miranda C, Sánchez G, et al. Treatment of chronic Chagas's disease with itraconazole and allopurinol. Am J Trop Med Hyg 1998; 59: 133-8.
2. Apt W, Arribada A, Zulantay I, Solari I, Sánchez G, Mundana K, et al. Itraconazole or allopurinol in the treatment of chronic american trypanosomiasis. The results of clinical and parasitological examinations 11 years post treatment. Ann Trop Med Parasitol 2005; 99: 733-41.
3. Apt W. Tratamiento de la enfermedad de Chagas. Parasitol Día 1999; 23.
4. Buckner F, Wilson A, White T C, Van Voohis W C. Induction of resistance to azole drugs in Trypanosoma cruzi. Antimicrob Agents Chemother 1998; 42: 3245-50.
5. Ferreira M S, Nishioska S, Silvestre M T, Vorges A S, Nunes Araujo F R, Rocha A. Reactivation of Chagas disease in patients with AIDS: Report of three new cases and review of the literature. Clin Infect Dis 1997; 25: 1397-400.
6. Fragata F A, Luquetti A, Prata A, Andrade A, Rassi A, Gontijo E et al. Etiological treatment of Chagas disease. Parasitol Today 1997; 12: 127-30.
7. Organización Panamericana de la Salud/Organización Mundial de la Salud. Tratamiento etiológico de la enfermedad de Chagas. Conclusiones de una consulta Técnica Fundación Oswaldo Cruz, Río de Janeiro 23-25 de abril 1998.
8. Reyes P A, Vallejo M. Trypanocidal drugs for late stage, symptomatic Chagas disease (Trypanosoma cruzi infection). Cochrane Database 2005 Oct 19; (4): 004102. Review.
9. Rodríguez Soura J, De Castro S L. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97: 3-24.
10. Rodríguez-Morales A J. Nuevas perspectivas en el manejo terapéutico de la enfermedad de Chagas. Rev Peru Med Exp Salud Pública 2005; 22: 113-33.
11. Schenone H, Contreras M, Solari A, García A, Rojas A, Lorca M. Tratamiento con nifurtimox en niños con infección chagásica. Rev Méd Chile 2003; 131: 1089-90.
12. Solari A, Saavedra H, Sepúlveda C, Oddo D, Acuña G, Labarca J. et al. Successful treatment of Trypanosoma cruzi encephalitis in a patients with hemophilia and AIDS Clin Infect Dis 1993; 16: 255-9.
13. Urbina J A. Specific treatment of Chagas disease: current status and new developments. Curr Opin Infect Dis 2001; 14: 733-41
14. Villar J C, Marin-Neto J A, Ebrahim S, Yusuf S. Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection. Cochrane Database Syst Rev 2002 (1): CD 003463. Review.